Temmler Pharma GmbH

Pharmaceutical Companies · Marburg-Biedenkopf

Temmler Pharma GmbH is a pharmaceutical company based in Marburg-Biedenkopf, Hesse, Germany. The company operates in the German pharmaceutical market and is regulated by the BfArM (Federal Institute for Drugs and Medical Devices).

Content in German

The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.

Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.

Temmler Pharma GmbH – Address & Contact

Address

Temmlerstr. 2
35039 Marburg-Biedenkopf

Temmler Pharma GmbH Overview

Temmler Pharma GmbH is a pharmaceutical company based in Marburg-Biedenkopf, Hessen. The company operates in the German pharmaceutical market and is regulated by the BfArM (Federal Institute for Drugs and Medical Devices).

Activities & Products

Pharmaceutical companies such as Temmler Pharma GmbH develop, produce or distribute medicines for the German and international market. All authorised products are subject to approval and are regulated by BfArM or the European Medicines Agency (EMA).

Location & Contact

Temmler Pharma GmbH can be reached at the following address: Temmlerstr. 2, 35039 Marburg-Biedenkopf – Phone: 06421494301. For current information and enquiries, please contact the company directly.

More information: Pharmaunternehmen in Hessen or all Pharmaunternehmen in Germany on Sanoliste.

Pharmazeutische Regulierung in Deutschland

Pharmaceutical companies such as Temmler Pharma GmbH are subject to one of the world's most stringent regulatory frameworks in Germany. The German Medicinal Products Act (AMG) governs the authorisation, manufacturing, distribution and monitoring of medicinal products. Market authorisation for new active substances falls under the responsibility of either the Federal Institute for Drugs and Medical Devices (BfArM) or the European Medicines Agency (EMA), depending on whether a national or centralised authorisation is sought.

Arzneimittelversorgung & Marktumfeld

With a revenue volume exceeding 50 billion euros, the German pharmaceutical market is one of the largest in Europe. Temmler Pharma GmbH, based in Marburg-Biedenkopf, is part of this market. The supply chain from manufacturer through wholesaler to pharmacy is governed by Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP). Since the entry into force of the Act for Greater Safety in the Medicinal Products Supply (GSAV), stricter requirements for the traceability of medicinal products also apply.

Pharmastandort Hessen

Hessen is a significant pharmaceutical location in Germany. Companies such as Temmler Pharma GmbH benefit from proximity to research institutions, university hospitals and well-developed infrastructure. The industry employs over 140,000 people in Germany and invests billions annually in research and development.

Frequently asked questions about Temmler Pharma GmbH

What does Temmler Pharma GmbH do?

Temmler Pharma GmbH arattet hauptsächlich im Auftrag for Dritte at the development, Zulassung and Produktion of medicinesn and Nahrungsergänzung and theen anschließendem distribution. Daat geht es neben Generika also um seltene neurologische Erkrankungen. Sie hat also einige Eigenmarken in ihrem Sortiment.

What medicines does Temmler Pharma GmbH manufacture?

Temmler Pharma GmbH is a pharmaceutical company in Marburg-Biedenkopf. Geschichte of Temmler Pharma GmbH Temmler Pharma GmbH, ein in Germany ansässiges Pharmaundernehmen, blickt on eine lange and bedeutende Geschichte zurück. Es wurde 1917 in B Alle in Germany zugelassenen medicines are in the medicines-Datenbank des BfArM recherchierbar.

How are medicines approved in Germany?

Neue medicines benötigen vor dem Inverkehrbringen eine Zulassung durch the BfArM (national) or the EMA (europaweit). Der Zulassungsprozess umfasst the Prüfung of quality, Wirksamkeit and Unbedenklichkeit on Basis präklinischer and klinischer Stuthen. Die Nutzenbewertung after § 35a SGB V entscheidet about the Erstattung durch the gesetzlichen Krankenkassen.

What does GMP mean in pharmaceutical production?

GMP (Good Manufacturing Practice) bezeichnet the Gute manufacturingspraxis – ein System of qualitysstandards, the sicherstellt, thes medicines gleichbleibend after den gefortheten qualitysnormen hergestellt and geprüft are. Die GMP-Richtlinien are in the EU durch den EudraLex Volume 4 definiert.

Pharmaceutical Companies in Hessen

All Pharmaceutical Companies in Hessen on Sanoliste — or discover all categories by federal state.

Last updated: 17.03.2026 · Category: Pharmaceutical Companies